Bereavement Management - Description, Assessment and Care

March 25, 2020 updated by: University of Aarhus

Bereavement Management. Description, Assessment and Care. A Randomized Controlled Study.

This study aims to develop a risk assessment tool to identify bereaved in risk of complicated grief reactions and to implement a bereavement management programme in primary health care based on the Dual Process Model of coping with bereavement. Furthermore to enhance bereavement care in general practice and to enhance patients' self-management in bereavement care.

Study Overview

Status

Completed

Conditions

Detailed Description

In Denmark alone there are approximately 55.000 deaths annually which leave approximately 200.000 bereaved close relatives. International studies show that 10-15% of bereaved persons develop complications following the death of a close relative. If those studies hold true, approximately 20 - 30.000 individuals annually will develop complications as a result of suffering a loss, and there is hardly any knowledge of how bereavement is treated or even legitimized in primary care and referred on to specialized (psychological or psychiatric) care. The field of bereavement is in need of studies that validate the theoretical underpinnings of the research area, enhanced assessment of predictive risk factors and updated intervention methods: in short a scientifically valid management programme.

Study Type

Interventional

Enrollment (Actual)

402

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Research unit for general practice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Newly bereaved from one of the inclusion facilities.
  • 18 years or older.
  • Danish citizen.
  • Able to understand and speak Danish.
  • Informed consent.
  • Mentally able to cooperate

Exclusion Criteria:

  • Patients with known substance abuse.
  • Patients with recently (within 5 years) diagnosed psychopathological disorders that trigger psychotic episodes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group

A) Professional level. B) Patient level.

Intervention

Professional level:

General Practitioners (GP) receive updated information on bereavement related symptoms, how to identify complicated grief, and the Dual Process Model (DPM) of coping.

GPs receive suggestions on how to provide psycho-educational support for the patient.

GPs are informed about the results of the initial assessment of their patient prognostic screening for complicated grief.

Patient level:

Patients receive updated information on bereavement related symptoms, the DPM of coping and suggestions on when to seek professional help.

Patients are informed of the results of their initial assessment of their prognostic grief screening.

Patients are encouraged to contact their GP if they worry about handling their bereavement reaction.

Patients in the intervention group are prognostically screened for development of complicated grief to identify those in need of help.
Other: Control group
Treatment as usual (in the Danish health care system).
Patients in the intervention group are prognostically screened for development of complicated grief to identify those in need of help.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of the intervention measured by an increase in the diagnosis of complicated grief.
Time Frame: 20 months
GPs receive updated information on bereavement related symptoms, how to identify complicated grief, and the Dual Process Model of coping.
20 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of the intervention measured by register-based data.
Time Frame: 20 months
Effect of the intervention measured by register-based data on frequency in contact with GP, referrals to psychological/psychiatric counselling, medicine consumption and use of emergency services.
20 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Frede Olesen, Professor, Research Unit for General Practice, Aarhus University, Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2009

Primary Completion (Actual)

January 1, 2012

Study Completion (Actual)

January 1, 2012

Study Registration Dates

First Submitted

February 8, 2011

First Submitted That Met QC Criteria

February 8, 2011

First Posted (Estimate)

February 9, 2011

Study Record Updates

Last Update Posted (Actual)

March 27, 2020

Last Update Submitted That Met QC Criteria

March 25, 2020

Last Verified

March 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • Bereavement Management.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Grief

Clinical Trials on Prognostic screening for complicated grief

Subscribe